Bristol-Myers Squibb Co
Federal judge declines to block Medicare drug price negotiations
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal judge on Friday declined to block the Biden administration from implementing Medicare drug price negotiations, upholding for now a controversial process that aims to make costly medications […]
Read More
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
In this photo illustration, Farxiga is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images AstraZeneca and Boehringer Ingelheim on Wednesday told CNBC they will agree to participate in the first round of Medicare drug price negotiations, even after both pharmaceutical companies […]
Read More
Judge withdraws from Medicare drug price case after stock ownership is revealed
Ohio Governor Mike DeWine, right, shakes hands with Judge Thomas Rose of the U.S. District Court Southern District of Ohio after taking his oath of office, Monday, Jan. 14, 2019, in Cedarville, Ohio. John Minchillo | AP A federal judge on Friday withdrew from a case that could block Medicare from negotiating over drug prices, […]
Read More
Medicare wants to cut the price on an Eli Lilly drug. What it means for LLY shares
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty […]
Read More
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
In this photo illustration, Eliquis is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images Medicare is set to negotiate prices for 10 different drugs with manufacturers in a bid to make those costly treatments more affordable for older Americans – a […]
Read More
Here are the three most used drugs on the Medicare price negotiation list
Bottles of the drug Jardiance, made by Eli Lilly and Company, sit on a counter at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters Two blood thinners and a diabetes medication are the most widely used among a list of ten drugs that will be subject to price negotiations between manufacturers […]
Read More
Biden administration unveils first 10 drugs subject to Medicare price negotiations
Kubra Cavus | Istock | Getty Images The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans. President Joe Biden’s Inflation Reduction Act, which passed in a […]
Read More
Why startups are investing thousands and thousands to make prescription drugs and semiconductors in house
In-area producing may audio like science fiction but it is going on previously, albeit on a very modest scale. It is really a fledgling market place that analysts and numerous startups are projecting will get off. “If you appear at pharma, semiconductors, splendor and health items and potentially foodstuff in the sense of like new […]
Read More
These 10 medications are likely targets for Medicare price negotiations this fall
Merck & Co. Inc. Januvia brand medication, used to treat type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in the program’s nearly six-decade history. The Centers for Medicare […]
Read More
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
Pavlo Gonchar | LightRocket | Getty Images Johnson & Johnson on Tuesday sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act. The lawsuit filed in federal district court in New Jersey argues the Medicare negotiations violate […]
Read More